skip to main content

Barbara Rowland Serves on Panel at the Pharmaceutical Compliance Congress and Best Practices Forum

October 21, 2015

On October 22, Internal Investigations & White Collar Defense Principal Barbara Rowland served on the panel discussion, Consolidation, Vertical Integration and Cross-Border Business: Confronting “Next Generation” Compliance Priorities, at the Pharmaceutical Compliance Forum's (PCF) Sixteenth Annual Pharmaceutical Compliance Congress and Best Practices Forum in Washington, D.C. 

Ms. Rowland's fellow panelists were:

  • Michael S. Blume, Esq., Director, Consumer Protection Branch, US Department of Justice, Civil Division
  • Jill Fallows-Macaluso, Vice President, Chief Compliance Officer, Novo Nordisk Inc.
  • Susan Williamson, Vice President and US Compliance Officer, Endo Pharmaceuticals
  • Kris Curry, MBA, Principal, Fraud Investigation & Dispute Services, Ernst & Young LLP

The PCF is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field.